I suspect the two major shareholders see TPM as a long term expansion play. Not that I have any problem with that.
OCC Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil
Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday